Estrogen and androgen signaling in the pathogenesis of BPH. (Q37828063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Estrogen and androgen signaling in the pathogenesis of BPH (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Fouad K Habib

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

29-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrurol.2010.207

19 January 2020

exact match

0 references

cites work

Regional morphology and pathology of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The endocrinology and developmental biology of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Prostate stem cells and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Natural potent androgens: lessons from human genetic models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Regulation of testicular function in men: implications for male hormonal contraceptive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen in the etiopathogenesis of BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Calculated free testosterone in men: comparison of four equations and with free androgen index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Chemistry and structural biology of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Androgen receptor expression in human tissues: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Role of 5 alpha-reductase in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Differential regulation of testosterone vs. 5alpha-dihydrotestosterone by selective androgen response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen receptor interaction with co-activators and co-repressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

CYP7B generates a selective estrogen receptor beta agonist in human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Serum sex hormones and measures of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Effects of androgen deficiency and replacement on prostate zonal volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Androgen receptor protein expression in prostatic tissues in Black and Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Expression of steroidogenic enzymes and sex-steroid receptors in human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Cloning, expression and functional characterization of type 1 and type 2 steroid 5 alpha-reductases from Cynomolgus monkey: comparisons with human and rat isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The localisation and expression of 5 alpha-reductase types I and II mRNAs in human hyperplastic prostate and in prostate primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Changes in the Metabolism of Dihydrotestosterone in the Hyperplastic Human Prostate*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Enzymes of Androgen Formation and Degradation in the Human Prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The induction of prostatic hypertrophy in the dog with androstanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Comparison of spontaneous and experimentally induced canine prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The identification and simultaneous quantification of 7-hydroxylated metabolites of pregnenolone, dehydroepiandrosterone, 3beta,17beta-androstenediol, and testosterone in human serum using gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

17Beta-estradiol at low concentrations acts through distinct pathways in normal versus benign prostatic hyperplasia-derived prostate stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen receptor expression in prostate cancer and premalignant prostatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Identification and characterization of estrogen receptor variants in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Cloning and characterization of human estrogen receptor beta isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Induction of apoptosis in human prostate stromal cells by 4-hydroxytamoxifen: an alternative therapy for benign prostate hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Physiology of the steroid-thyroid hormone nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Aromatase and intracrinology of estrogen in hormone-dependent tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Conversion of Androstenedione to Estrone in Human Fibroblasts Cultured from Prostate, Genital and Nongenital Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Effects of estrogen deprivation on human benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The putative androgen receptor-A form results from in vitro proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Study of 202 Natural, Synthetic, and Environmental Chemicals for Binding to the Androgen Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Polymorphisms in the Vitamin D Receptor Gene and the Androgen Receptor Gene and the Risk of Benign Prostatic Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Human prostatic cells in culture: Different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Plasma androgens in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The Natural History and Course of Untreated Benign Prostatic Hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The development of human benign prostatic hyperplasia with age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

A and B forms of the androgen receptor are expressed in a variety of human tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

A new actor in the estrogen receptor drama--enter ER-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The effect of orchiectomy and estrogens of benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Potential activities of androgen metabolizing enzymes in human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Cell type specific expression of steroid 5 alpha-reductase 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Kinetic analysis of steroid 5alpha-reductase activity at neutral pH in benign prostatic hyperplastic tissue: evidence for type I isozyme activity in the human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Herbal medications in the treatment of benign prostatic hyperplasia (BPH)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estradiol in elderly men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Intratissular androgens in benign prostatic hyperplasia and prostatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen receptor β expression in human prostate tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Selective estrogen receptor modulators: structure, function, and clinical use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Immunolocalization of oestrogen and progesterone receptors in prostatic hyperplasia and carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Aromatase in hyperplasia and carcinoma of the human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Aromatase mRNA levels in benign prostatic hyperplasia and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Expression of enzymes involved in estrogen metabolism in human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Failure of human benign prostatic hyperplasia to aromatise testosterone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen formation in human prostatic tissue from patients with and without benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

The possibility of aromatization of androgen in human prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.207

Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR.

31 March 2020

1 reference

12 December 2020

Intratumoral aromatase in human breast, endometrial, and ovarian malignancies

1 reference

12 December 2020

Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency

1 reference

12 December 2020

Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone

1 reference

12 December 2020

Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis

1 reference

12 December 2020

Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism

1 reference

12 December 2020

Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate

1 reference

12 December 2020

Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia.

1 reference

12 December 2020

In vivo uptake and metabolism of 3H-testosterone and 3H-5 -dihydrotestosterone by human benign prostatic hypertrophy.

1 reference

12 December 2020

Steroid 5 alpha-reductase 2 deficiency

1 reference

12 December 2020

Hormonal control of sexual development

1 reference

12 December 2020

Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes

1 reference

12 December 2020

Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation

1 reference

12 December 2020

Estrogen receptors: selective ligands, partners, and distinctive pharmacology

1 reference

12 December 2020

Aromatase expression in health and disease

1 reference

12 December 2020

Origin and evolution of benign prostatic enlargement

1 reference

12 December 2020

Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia

1 reference

12 December 2020

The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates

1 reference

12 December 2020

The androgen receptor: an overview.

1 reference

12 December 2020

Etiology and disease process of benign prostatic hyperplasia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2010.207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21228820%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference